In this model, UFT showed a strong angiogenesis - inhibitory effect, whereas 5 - fluorouracil ( 5 - FU) and doxifluridine were less effective.	"UFT	15	18	Chemical"	"5 - fluorouracil	77	93	Chemical"	"5 - FU	96	102	Chemical"	"doxifluridine	108	121	Chemical"	"[{""token"": ""UFT"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""5 - fluorouracil"", ""start_span"": 77, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 96, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""doxifluridine"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Chemical""}]"
The anti - tumour effect of L - NAME after systemic administration was studied in a renal subcapsular CC531 adenocarcinoma model in rats.	"tumour	11	17	Cancer"	"L - NAME	28	36	Chemical"	"renal subcapsular CC531 adenocarcinoma	84	122	Cancer"	"rats	132	136	Organism"	"[{""token"": ""tumour"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""L - NAME"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""renal subcapsular CC531 adenocarcinoma"", ""start_span"": 84, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""rats"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organism""}]"
In combination with TNF or melphalan, L - NAME increased response rates significantly compared to perfusions without L - NAME ( 0 - 64% and 0 - 63% respectively).	"TNF	20	23	Gene_or_gene_product"	"melphalan	27	36	Chemical"	"L - NAME	38	46	Chemical"	"L - NAME	117	125	Chemical"	"[{""token"": ""TNF"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""melphalan"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""L - NAME"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""L - NAME"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Chemical""}]"
An additional anti - tumour effect was demonstrated when L - NAME was added to the synergistic combination of melphalan and TNF ( responses increased from 70 to 100%).	"tumour	21	27	Cancer"	"L - NAME	57	65	Chemical"	"melphalan	110	119	Chemical"	"TNF	124	127	Gene_or_gene_product"	"[{""token"": ""tumour"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""L - NAME"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Chemical""}, {""token"": ""melphalan"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""TNF"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"
A synergistic anti - tumour effect of L - NAME is observed in combination with melphalan and / or TNF using ILP.	"tumour	21	27	Cancer"	"L - NAME	38	46	Chemical"	"melphalan	79	88	Chemical"	"TNF	98	101	Gene_or_gene_product"	"[{""token"": ""tumour"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""L - NAME"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""melphalan"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""TNF"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"
The efficacy of the antitumor activity of 1 ' - acetoxychavicol acetate ( ACA), reported to be a suppressor of chemically induced carcinogenesis, was evaluated in Ehrlich ascites tumor cells.	"antitumor	20	29	Cancer"	"1 ' - acetoxychavicol acetate	42	71	Chemical"	"ACA	74	77	Chemical"	"Ehrlich ascites tumor cells	163	190	Cell"	"[{""token"": ""antitumor"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""1 ' - acetoxychavicol acetate"", ""start_span"": 42, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""ACA"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 163, ""end_span"": 190, ""type"": ""Cell""}]"
Apoptosis, characterized by nuclear condensation, membrane blebbing, cell shrinkage and a significant induction of caspase - 3 - like protease activity at 8 h in a time - course study were observed.	"nuclear	28	35	Cellular_component"	"membrane	50	58	Cellular_component"	"cell	69	73	Cell"	"caspase - 3 - like protease	115	142	Gene_or_gene_product"	"[{""token"": ""nuclear"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Cellular_component""}, {""token"": ""membrane"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""caspase - 3 - like protease"", ""start_span"": 115, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"
Vascular endothelial growth factor - B and vascular endothelial growth factor - C expression in renal cell carcinomas: regulation by the von Hippel - Lindau gene and hypoxia.	"Vascular endothelial growth factor - B	0	38	Gene_or_gene_product"	"vascular endothelial growth factor - C	43	81	Gene_or_gene_product"	"renal cell carcinomas	96	117	Cancer"	"von Hippel - Lindau	137	156	Gene_or_gene_product"	"[{""token"": ""Vascular endothelial growth factor - B"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor - C"", ""start_span"": 43, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinomas"", ""start_span"": 96, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""von Hippel - Lindau"", ""start_span"": 137, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"
We observed a significant up - regulation of VEGF - B ( P = 0. 002) but not VEGF - C ( P = 0. 3) in neoplastic kidney compared with normal tissues.	"VEGF - B	45	53	Gene_or_gene_product"	"VEGF - C	76	84	Gene_or_gene_product"	"neoplastic kidney	100	117	Organ"	"normal tissues	132	146	Tissue"	"[{""token"": ""VEGF - B"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplastic kidney"", ""start_span"": 100, ""end_span"": 117, ""type"": ""Organ""}, {""token"": ""normal tissues"", ""start_span"": 132, ""end_span"": 146, ""type"": ""Tissue""}]"
One of the most common signatures of highly malignant tumors is their capacity to metabolize more glucose to lactic acid than their tissues of origin.	"malignant tumors	44	60	Cancer"	"glucose	98	105	Chemical"	"lactic acid	109	120	Chemical"	"tissues	132	139	Tissue"	"[{""token"": ""malignant tumors"", ""start_span"": 44, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""lactic acid"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""tissues"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Tissue""}]"
Membrane - anchored Cbl suppresses Hck protein - tyrosine kinase mediated cellular transformation.	"Cbl	20	23	Gene_or_gene_product"	"Hck	35	38	Gene_or_gene_product"	"tyrosine	49	57	Amino_acid"	"cellular	74	82	Cell"	"[{""token"": ""Cbl"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hck"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Amino_acid""}, {""token"": ""cellular"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Cell""}]"
Activated Hck and membrane - anchored Cbl are present in similar subcellular localizations and co - immunoprecipitate, suggesting that their interaction is required for subsequent ubiquitination and degradation.	"Hck	10	13	Gene_or_gene_product"	"membrane	18	26	Cellular_component"	"Cbl	38	41	Gene_or_gene_product"	"subcellular	65	76	Cellular_component"	"[{""token"": ""Hck"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""Cbl"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""subcellular"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Cellular_component""}]"
The finding of retinal vasculopathy ( 32 patients in group 1 and two patients in group 2) was directly correlated with the presence of choroidal neovascularizations ( P = 0. 002).	"retinal	15	22	Multi"	"patients	41	49	Organism"	"patients	69	77	Organism"	"choroidal	135	144	Multi"	"[{""token"": ""retinal"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""choroidal"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Multi""}]"
We undertook this study to test the hypothesis that Fas - FasL - mediated apoptosis plays a role in IL - 12 - induced tumor regression.	"Fas	52	55	Gene_or_gene_product"	"FasL	58	62	Gene_or_gene_product"	"IL - 12	100	107	Gene_or_gene_product"	"tumor	118	123	Cancer"	"[{""token"": ""Fas"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Cancer""}]"
Fas and FasL proteins were increased approximately twofold in the RM - 9 - IL12 tumors compared with the RM - 9 control tumors as determined by Western blot and immunohistochemical analyses ( P < 0. 05).	"Fas	0	3	Gene_or_gene_product"	"FasL	8	12	Gene_or_gene_product"	"RM - 9 - IL12 tumors	66	86	Cancer"	"RM - 9 control tumors	105	126	Cancer"	"[{""token"": ""Fas"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""RM - 9 - IL12 tumors"", ""start_span"": 66, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""RM - 9 control tumors"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Cancer""}]"
CONCLUSION: The Fas - FasL - mediated apoptosis pathway may contribute to the IL - 12 - induced rejection of prostate carcinoma.	"Fas	16	19	Gene_or_gene_product"	"FasL	22	26	Gene_or_gene_product"	"IL - 12	78	85	Gene_or_gene_product"	"prostate carcinoma	109	127	Cancer"	"[{""token"": ""Fas"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate carcinoma"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Cancer""}]"
The dominant negative mutant of Rac1 completely inhibited ephrin - B1 - induced membrane ruffling and focal complex assembly.	"Rac1	32	36	Gene_or_gene_product"	"ephrin - B1	58	69	Gene_or_gene_product"	"membrane	80	88	Cellular_component"	"focal complex	102	115	Cellular_component"	"[{""token"": ""Rac1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Cellular_component""}, {""token"": ""focal complex"", ""start_span"": 102, ""end_span"": 115, ""type"": ""Cellular_component""}]"
In contrast, rap1GAPII, a negative regulator of Rap1, did not inhibit ephrin - B1 - induced membrane ruffling.	"rap1GAPII	13	22	Gene_or_gene_product"	"Rap1	48	52	Gene_or_gene_product"	"ephrin - B1	70	81	Gene_or_gene_product"	"membrane	92	100	Cellular_component"	"[{""token"": ""rap1GAPII"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rap1"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Cellular_component""}]"
However, in rap1GAPII - expressing cells, ephrin - B1 did not induce membrane spreading, probably due to instability of the focal complex.	"rap1GAPII	12	21	Gene_or_gene_product"	"ephrin - B1	42	53	Gene_or_gene_product"	"membrane	69	77	Cellular_component"	"focal complex	124	137	Cellular_component"	"[{""token"": ""rap1GAPII"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""focal complex"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Cellular_component""}]"
FVIIa - induced antiapoptotic effect was dependent on its proteolytic activity and TF but independent of factor Xa and thrombin.	"FVIIa	0	5	Gene_or_gene_product"	"TF	83	85	Gene_or_gene_product"	"factor Xa	105	114	Gene_or_gene_product"	"thrombin	119	127	Gene_or_gene_product"	"[{""token"": ""FVIIa"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""factor Xa"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"
Cloning and characterization of the latent membrane protein ( LMP) of a specific Epstein - Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.	"latent membrane protein	36	59	Gene_or_gene_product"	"LMP	62	65	Gene_or_gene_product"	"Epstein - Barr virus	81	101	Organism"	"nasopharyngeal carcinoma	127	151	Cancer"	"[{""token"": ""latent membrane protein"", ""start_span"": 36, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 127, ""end_span"": 151, ""type"": ""Cancer""}]"
A DNA fragment containing Epstein - Barr virus ( EBV) terminal fragment sequence was obtained from a genomic library of nasopharyngeal carcinoma ( NPC).	"Epstein - Barr virus	26	46	Organism"	"EBV	49	52	Organism"	"nasopharyngeal carcinoma	120	144	Cancer"	"NPC	147	150	Cancer"	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 120, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""NPC"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Cancer""}]"
Indeed, we would hypothesize that these angiogenic markers - - especially the angiopoietins - - do not necessarily translate into new vessel formation in congestive heart failure ( CHF), but may well reflect disturbances of endothelial integrity in CHF.	"angiopoietins	78	91	Gene_or_gene_product"	"vessel	134	140	Multi"	"heart	165	170	Organ"	"endothelial	224	235	Tissue"	"[{""token"": ""angiopoietins"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessel"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Multi""}, {""token"": ""heart"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Organ""}, {""token"": ""endothelial"", ""start_span"": 224, ""end_span"": 235, ""type"": ""Tissue""}]"
[ Correlation between expression of vascular endothelial growth factor - C in tumor - associated macrophages and lymphatic metastasis in oral cancer].	"vascular endothelial growth factor - C	36	74	Gene_or_gene_product"	"tumor - associated macrophages	78	108	Cell"	"lymphatic	113	122	Organ"	"oral cancer	137	148	Cancer"	"[{""token"": ""vascular endothelial growth factor - C"", ""start_span"": 36, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor - associated macrophages"", ""start_span"": 78, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""lymphatic"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Organ""}, {""token"": ""oral cancer"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Cancer""}]"
In addition, the hypothesis predicts that early detection, which is designed to find more patients without involved lymph nodes, may not be a synergistic strategy with adjuvant chemotherapy, which works best with positive lymph node patients.	"patients	90	98	Organism"	"lymph nodes	116	127	Multi"	"lymph node	222	232	Multi"	"patients	233	241	Organism"	"[{""token"": ""patients"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""lymph nodes"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Multi""}, {""token"": ""lymph node"", ""start_span"": 222, ""end_span"": 232, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 233, ""end_span"": 241, ""type"": ""Organism""}]"
Vascular endothelial growth factor ( VEGF) is a vascular growth factor which induces angiogenesis ( the development of new blood vessels), vascular permeability, and inflammation.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"blood vessels	123	136	Multi"	"vascular	139	147	Multi"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Multi""}, {""token"": ""vascular"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Multi""}]"
Eligible patients had CNV in which the central boundary of the lesion was between 1 and 199 microm from the geometric center of the foveal avascular zone ( FAZ).	"patients	9	17	Organism"	"lesion	63	69	Pathological_formation"	"foveal avascular zone	132	153	Tissue"	"FAZ	156	159	Tissue"	"[{""token"": ""patients"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""lesion"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Pathological_formation""}, {""token"": ""foveal avascular zone"", ""start_span"": 132, ""end_span"": 153, ""type"": ""Tissue""}, {""token"": ""FAZ"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Tissue""}]"
To define these roles more clearly, we examined the expression of DCC and its ligand, netrin - 1, in the normal endometrium and in endometrial cancer.	"DCC	66	69	Gene_or_gene_product"	"netrin - 1	86	96	Gene_or_gene_product"	"endometrium	112	123	Multi"	"endometrial cancer	131	149	Cancer"	"[{""token"": ""DCC"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""endometrium"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Multi""}, {""token"": ""endometrial cancer"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Cancer""}]"
METHODS: The expression of DCC and netrin - 1 in normal endometrial glands and in cancer cell lines was examined by RT - PCR and immunohistochemistry.	"DCC	27	30	Gene_or_gene_product"	"netrin - 1	35	45	Gene_or_gene_product"	"endometrial glands	56	74	Multi"	"cancer cell lines	82	99	Cell"	"[{""token"": ""DCC"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""endometrial glands"", ""start_span"": 56, ""end_span"": 74, ""type"": ""Multi""}, {""token"": ""cancer cell lines"", ""start_span"": 82, ""end_span"": 99, ""type"": ""Cell""}]"
CONCLUSION: Our observations suggest that DCC / netrin - 1 signaling may commit cells to the transition of endometrial gland architecture or function from a proliferating to a secretory phase.	"DCC	42	45	Gene_or_gene_product"	"netrin - 1	48	58	Gene_or_gene_product"	"cells	80	85	Cell"	"endometrial gland	107	124	Multi"	"[{""token"": ""DCC"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""endometrial gland"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Multi""}]"
Group 2 was treated by Enoxaparine Na, group 3 received HBO therapy, and group 4 was given both enoxaparine Na and HBO treatment.	"Enoxaparine Na	23	37	Chemical"	"HBO	56	59	Chemical"	"enoxaparine Na	96	110	Chemical"	"HBO	115	118	Chemical"	"[{""token"": ""Enoxaparine Na"", ""start_span"": 23, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""HBO"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""enoxaparine Na"", ""start_span"": 96, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""HBO"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Chemical""}]"
Enoxaparine Na had no harmful effects on wound healing, and HBO therapy increased the process of wound healing.	"Enoxaparine Na	0	14	Chemical"	"wound	41	46	Pathological_formation"	"HBO	60	63	Chemical"	"wound	97	102	Pathological_formation"	"[{""token"": ""Enoxaparine Na"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Pathological_formation""}, {""token"": ""HBO"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Pathological_formation""}]"
The results showed that thrombospondin is expressed in normal prostate but not in prostate tumours in a rat model.	"thrombospondin	24	38	Gene_or_gene_product"	"prostate	62	70	Organ"	"prostate tumours	82	98	Cancer"	"rat	104	107	Organism"	"[{""token"": ""thrombospondin"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Organ""}, {""token"": ""prostate tumours"", ""start_span"": 82, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""rat"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism""}]"
Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding.	"Bovine papillomavirus	0	21	Organism"	"E7	22	24	Gene_or_gene_product"	"cellular	65	73	Cell"	"p600	74	78	Gene_or_gene_product"	"[{""token"": ""Bovine papillomavirus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 22, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""p600"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}]"
To address this question, we used the proteomic approach of tandem affinity purification to identify cellular proteins that are in complex with E7, and identified the 600 - kDa protein, p600, as a binding partner of E7.	"cellular	101	109	Cell"	"E7	144	146	Gene_or_gene_product"	"p600	186	190	Gene_or_gene_product"	"E7	216	218	Gene_or_gene_product"	"[{""token"": ""cellular"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""E7"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""p600"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 216, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"
Epithelial - mesenchymal transitions ( EMTs) occur as key steps during embryonic morphogenesis, and are now implicated in the progression of primary tumors towards metastases.	"Epithelial	0	10	Cell"	"mesenchymal	13	24	Cell"	"embryonic	71	80	Developing_anatomical_structure"	"tumors	149	155	Cancer"	"[{""token"": ""Epithelial"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Cell""}, {""token"": ""mesenchymal"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Developing_anatomical_structure""}, {""token"": ""tumors"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Cancer""}]"
Single cell transplants showed that a common precursor contributes to both the hemopoietic and endothelial lineages, thus demonstrating the presence of an adult hemangioblast.	"cell	7	11	Cell"	"hemopoietic	79	90	Cell"	"endothelial lineages	95	115	Cell"	"hemangioblast	161	174	Cell"	"[{""token"": ""cell"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""hemopoietic"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""endothelial lineages"", ""start_span"": 95, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""hemangioblast"", ""start_span"": 161, ""end_span"": 174, ""type"": ""Cell""}]"
By ruling out cell fusion, we clearly demonstrate the existence of an adult hemangioblast, but the differentiation of marrow stem cells toward the endothelial lineage is an extremely rare event.	"cell	14	18	Cell"	"hemangioblast	76	89	Cell"	"marrow stem cells	118	135	Cell"	"endothelial lineage	147	166	Cell"	"[{""token"": ""cell"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""hemangioblast"", ""start_span"": 76, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""marrow stem cells"", ""start_span"": 118, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""endothelial lineage"", ""start_span"": 147, ""end_span"": 166, ""type"": ""Cell""}]"
After MNNG administration, rats were investigated by endoscopic observation, visualization of microvascular structure, and estimation of lectin binding sites.	"MNNG	6	10	Chemical"	"rats	27	31	Organism"	"microvascular	94	107	Tissue"	"lectin	137	143	Gene_or_gene_product"	"[{""token"": ""MNNG"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""microvascular"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Tissue""}, {""token"": ""lectin"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"
Protruding and expansive ulcerating carcinomas developed at 36 weeks and had a microvascular pattern similar to that of human adenocarcinoma.	"ulcerating carcinomas	25	46	Cancer"	"microvascular	79	92	Tissue"	"human	120	125	Organism"	"adenocarcinoma	126	140	Cancer"	"[{""token"": ""ulcerating carcinomas"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""microvascular"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Organism""}, {""token"": ""adenocarcinoma"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Cancer""}]"
We postulate that endoscopic observation is valuable in investigating the development of gastric carcinoma, and microvascular structure and lectin binding pattern may be useful to demonstrate the mechanism of growth of gastric carcinoma.	"gastric carcinoma	89	106	Cancer"	"microvascular	112	125	Tissue"	"lectin	140	146	Gene_or_gene_product"	"gastric carcinoma	219	236	Cancer"	"[{""token"": ""gastric carcinoma"", ""start_span"": 89, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""microvascular"", ""start_span"": 112, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""lectin"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 219, ""end_span"": 236, ""type"": ""Cancer""}]"
Thus, c - myc induction is a resistance factor and our findings suggest that tumors carrying low levels of c - Myc protein could be more responsive to vinca alkaloids treatment.	"c - myc	6	13	Gene_or_gene_product"	"tumors	77	83	Cancer"	"c - Myc	107	114	Gene_or_gene_product"	"vinca alkaloids	151	166	Chemical"	"[{""token"": ""c - myc"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""c - Myc"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""vinca alkaloids"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Chemical""}]"
Recently, it has been shown that expression of human HOX 2 genes is sequentially activated by RA beginning from Hox 2. 9 at the 3 ' end of the HOX 2 cluster ( A. Simeone, D. Acampora, L. Arcioni, P. W. Andrews, E. Boncinelli, and F. Mavilio, Nature [ London] 346: 763 - 766, 1990).	"human	47	52	Organism"	"HOX 2	53	58	Gene_or_gene_product"	"RA	94	96	Chemical"	"HOX 2	143	148	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""HOX 2"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""RA"", ""start_span"": 94, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""HOX 2"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}]"
However, in N - ras - transformed cell clones, RA - induced expression of these homeobox genes is delayed.	"N - ras	12	19	Gene_or_gene_product"	"cell clones	34	45	Cell"	"RA	47	49	Chemical"	"homeobox	80	88	Gene_or_gene_product"	"[{""token"": ""N - ras"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell clones"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""RA"", ""start_span"": 47, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""homeobox"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"
"High - Dose celecoxib and metronomic "" low - dose "" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non - Hodgkin ' s lymphoma."	"celecoxib	12	21	Chemical"	"cyclophosphamide	52	68	Chemical"	"patients	105	113	Organism"	"non - Hodgkin ' s lymphoma	164	190	Cancer"	"[{""token"": ""celecoxib"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""cyclophosphamide"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""non - Hodgkin ' s lymphoma"", ""start_span"": 164, ""end_span"": 190, ""type"": ""Cancer""}]"
EXPERIMENTAL DESIGN: We assessed response, toxicity, and biomarkers of angiogenesis to low - dose cyclophosphamide ( 50 mg p. o. o. d.) and high - dose celecoxib ( 400 mg p. o. b. i. d.) in adult patients with relapsed or refractory aggressive non - Hodgkin ' s lymphoma in a multicenter phase II prospective study.	"cyclophosphamide	98	114	Chemical"	"celecoxib	152	161	Chemical"	"patients	196	204	Organism"	"non - Hodgkin ' s lymphoma	244	270	Cancer"	"[{""token"": ""cyclophosphamide"", ""start_span"": 98, ""end_span"": 114, ""type"": ""Chemical""}, {""token"": ""celecoxib"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Organism""}, {""token"": ""non - Hodgkin ' s lymphoma"", ""start_span"": 244, ""end_span"": 270, ""type"": ""Cancer""}]"
Circulating endothelial cells and their precursors declined and remained low in responders, whereas plasma vascular endothelial growth factor trended to decline in responding patients but increase in nonresponders.	"endothelial cells	12	29	Cell"	"plasma	100	106	Organism_substance"	"vascular endothelial growth factor	107	141	Gene_or_gene_product"	"patients	175	183	Organism"	"[{""token"": ""endothelial cells"", ""start_span"": 12, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""plasma"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Organism_substance""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 107, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Organism""}]"
Recent advances in stem cell biology added the new concept that cancer originates from a single cancer - initiating cell.	"stem cell	19	28	Cell"	"cancer	64	70	Cancer"	"cancer	96	102	Cancer"	"cell	116	120	Cell"	"[{""token"": ""stem cell"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 96, ""end_span"": 102, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Cell""}]"
As expected, Ang II - induced sFlt - 1 secretion resulted in the inhibition of endothelial cell migration and in vitro tube formation.	"Ang II	13	19	Gene_or_gene_product"	"sFlt - 1	30	38	Gene_or_gene_product"	"endothelial cell	79	95	Cell"	"tube	119	123	Tissue"	"[{""token"": ""Ang II"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 79, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Tissue""}]"
The p53 protein suppresses tumorigenesis by initiating cellular functions such as cell cycle arrest and apoptosis in response to DNA damage.	"p53	4	7	Gene_or_gene_product"	"cellular	55	63	Cell"	"cell	82	86	Cell"	"DNA	129	132	Cellular_component"	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Cellular_component""}]"
Concomitantly, immunostaining for apoptosis inducing factor ( AIF) showed a time - dependent translocation from the mitochondria to the nucleus.	"apoptosis inducing factor	34	59	Gene_or_gene_product"	"AIF	62	65	Gene_or_gene_product"	"mitochondria	116	128	Cellular_component"	"nucleus	136	143	Cellular_component"	"[{""token"": ""apoptosis inducing factor"", ""start_span"": 34, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""AIF"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Cellular_component""}, {""token"": ""nucleus"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Cellular_component""}]"
These studies have led to the hypothesis that increased consumption of glucose in metastatic lesions is not used for substantial energy production via Embden - Meyerhoff glycolysis, but rather for production of acid, which gives the cancer cells a competitive advantage for invasion.	"glucose	71	78	Chemical"	"metastatic lesions	82	100	Cancer"	"acid	211	215	Chemical"	"cancer cells	233	245	Cell"	"[{""token"": ""glucose"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""metastatic lesions"", ""start_span"": 82, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""acid"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 233, ""end_span"": 245, ""type"": ""Cell""}]"
We found a decrease in corneal neovascularization in spironolactone - treated rats compared with the PBS - treated group, although the difference was not statistically significant.	"corneal	23	30	Multi"	"spironolactone	53	67	Chemical"	"rats	78	82	Organism"	"PBS	101	104	Chemical"	"[{""token"": ""corneal"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Multi""}, {""token"": ""spironolactone"", ""start_span"": 53, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""PBS"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Chemical""}]"
In conclusion, FAS - 1377 G - - > A polymorphism may be associated with an increased risk of lymph node metastasis in Korean cervical cancer patients.	"FAS	15	18	Gene_or_gene_product"	"lymph node	93	103	Multi"	"cervical cancer	125	140	Cancer"	"patients	141	149	Organism"	"[{""token"": ""FAS"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""cervical cancer"", ""start_span"": 125, ""end_span"": 140, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Organism""}]"
Survivin partially antagonized the growth suppressive function of N - myc in SH - EP neuroblastoma cells during serum deprivation whereas FLIP ( L) did not.	"Survivin	0	8	Gene_or_gene_product"	"N - myc	66	73	Gene_or_gene_product"	"SH - EP neuroblastoma cells	77	104	Cell"	"serum	112	117	Organism_substance"	"[{""token"": ""Survivin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - myc"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""SH - EP neuroblastoma cells"", ""start_span"": 77, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism_substance""}]"
In vivo, cediranib ( 6 mg / kg / d) prevented angiogenesis and lymphangiogenesis induced by VEGF - E - expressing and VEGF - C156S - expressing adenoviruses, respectively.	"cediranib	9	18	Chemical"	"VEGF - E	92	100	Gene_or_gene_product"	"VEGF - C156S	118	130	Gene_or_gene_product"	"adenoviruses	144	156	Organism"	"[{""token"": ""cediranib"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""VEGF - E"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C156S"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenoviruses"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Organism""}]"
Cediranib may, therefore, be an effective means of preventing tumor progression, not only by inhibiting VEGFR - 2 activity and angiogenesis, but also by concomitantly inhibiting VEGFR - 3 activity and lymphangiogenesis.	"Cediranib	0	9	Chemical"	"tumor	62	67	Cancer"	"VEGFR - 2	104	113	Gene_or_gene_product"	"VEGFR - 3	178	187	Gene_or_gene_product"	"[{""token"": ""Cediranib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""VEGFR - 2"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 3"", ""start_span"": 178, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"
These data indicate that artemisinin may be useful for the prevention of lymph node metastasis by downregulating VEGF - C and reducing tumor lymphangiogenesis.	"artemisinin	25	36	Chemical"	"lymph node	73	83	Multi"	"VEGF - C	113	121	Gene_or_gene_product"	"tumor	135	140	Cancer"	"[{""token"": ""artemisinin"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""lymph node"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Multi""}, {""token"": ""VEGF - C"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Cancer""}]"
The authors report on a case series of 13 patients with recurrent heavily pretreated malignant glioma that was treated with the combination of bevacizumab and irinotecan.	"patients	42	50	Organism"	"malignant glioma	85	101	Cancer"	"bevacizumab	143	154	Chemical"	"irinotecan	159	169	Chemical"	"[{""token"": ""patients"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""malignant glioma"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""bevacizumab"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical""}, {""token"": ""irinotecan"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Chemical""}]"
CONCLUSIONS: The combination of bevacizumab and irinotecan is safe and has excellent activity even in this relapsed, heavily pretreated population of patients with high - grade malignant glioma, most of whom would not be candidates for clinical trials.	"bevacizumab	32	43	Chemical"	"irinotecan	48	58	Chemical"	"patients	150	158	Organism"	"malignant glioma	177	193	Cancer"	"[{""token"": ""bevacizumab"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""irinotecan"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Organism""}, {""token"": ""malignant glioma"", ""start_span"": 177, ""end_span"": 193, ""type"": ""Cancer""}]"
Anti - endosialin was capable of preventing pericyte tube formation in culture and inhibited migration.	"Anti - endosialin	0	17	Gene_or_gene_product"	"pericyte	44	52	Cell"	"tube	53	57	Tissue"	"culture	71	78	Cell"	"[{""token"": ""Anti - endosialin"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericyte"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Tissue""}, {""token"": ""culture"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Cell""}]"
The data indicate that endosialin is strongly expressed by pericytes during periods of active angiogenesis during embryonic and tumor development.	"endosialin	23	33	Gene_or_gene_product"	"pericytes	59	68	Cell"	"embryonic	114	123	Developing_anatomical_structure"	"tumor	128	133	Cancer"	"[{""token"": ""endosialin"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericytes"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Developing_anatomical_structure""}, {""token"": ""tumor"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Cancer""}]"
METHODS: Ovarian cancer SKOV3 cells were transfected with hPNAS - 4 - plasmid, and cell proliferation was evaluated by MTT assay; apoptosis was examined by DNA ladder, Hoechst33258 staining and flow - cytometric assays.	"Ovarian cancer SKOV3 cells	9	35	Cell"	"hPNAS - 4	58	67	Gene_or_gene_product"	"cell	83	87	Cell"	"DNA	156	159	Cellular_component"	"[{""token"": ""Ovarian cancer SKOV3 cells"", ""start_span"": 9, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""hPNAS - 4"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Cellular_component""}]"
Nude mice bearing ovarian cancers were treated with hPNAS - 4 - p / liposome.	"Nude mice	0	9	Organism"	"ovarian cancers	18	33	Cancer"	"hPNAS - 4	52	61	Gene_or_gene_product"	"liposome	68	76	Chemical"	"[{""token"": ""Nude mice"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""ovarian cancers"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""hPNAS - 4"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""liposome"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Chemical""}]"
The objective of this study was to ascertain whether STX243 is more active in vivo than the clinically relevant drug 2 - methoxyoestradiol ( 2 - MeOE2) and the structurally similar compound 2 - MeOE2 - 3, 17 - O, O - bis - sulphamate ( STX140).	"STX243	53	59	Chemical"	"2 - methoxyoestradiol	117	138	Chemical"	"2 - MeOE2	141	150	Chemical"	"STX140	236	242	Chemical"	"[{""token"": ""STX243"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""2 - methoxyoestradiol"", ""start_span"": 117, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""2 - MeOE2"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Chemical""}, {""token"": ""STX140"", ""start_span"": 236, ""end_span"": 242, ""type"": ""Chemical""}]"
Both STX243 and STX140 were capable of retarding the growth of MDA - MB - 231 xenograft tumours ( 72 and 63%, respectively), whereas no inhibition was observed for animals treated with 2 - MeOE2.	"STX243	5	11	Chemical"	"STX140	16	22	Chemical"	"MDA - MB - 231 xenograft tumours	63	95	Cancer"	"2 - MeOE2	185	194	Chemical"	"[{""token"": ""STX243"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""STX140"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""MDA - MB - 231 xenograft tumours"", ""start_span"": 63, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""2 - MeOE2"", ""start_span"": 185, ""end_span"": 194, ""type"": ""Chemical""}]"
GSE could also inhibit the VEGF receptor / mitogen - activated protein kinase - mediated signaling pathway in endothelial cells.	"GSE	0	3	Organism_substance"	"VEGF receptor	27	40	Gene_or_gene_product"	"mitogen - activated protein kinase	43	77	Gene_or_gene_product"	"endothelial cells	110	127	Cell"	"[{""token"": ""GSE"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Organism_substance""}, {""token"": ""VEGF receptor"", ""start_span"": 27, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 43, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 110, ""end_span"": 127, ""type"": ""Cell""}]"
Role of the interferon - inducible IFI16 gene in the induction of ICAM - 1 by TNF - alpha.	"interferon	12	22	Gene_or_gene_product"	"IFI16	35	40	Gene_or_gene_product"	"ICAM - 1	66	74	Gene_or_gene_product"	"TNF - alpha	78	89	Gene_or_gene_product"	"[{""token"": ""interferon"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"
In the current study, the impact of VEGF expression on the response of tumors to the VEGFR2 associated tyrosine kinase inhibitor vandetanib was evaluated.	"VEGF	36	40	Gene_or_gene_product"	"tumors	71	77	Cancer"	"VEGFR2	85	91	Gene_or_gene_product"	"vandetanib	129	139	Chemical"	"[{""token"": ""VEGF"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""VEGFR2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""vandetanib"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Chemical""}]"
RESULTS: Vandetanib treatment had no effect on tumor cell clonogenic cell survival in vitro but doses > or = 10 nM significantly reduced endothelial cell migration.	"Vandetanib	9	19	Chemical"	"tumor cell	47	57	Cell"	"cell	69	73	Cell"	"endothelial cell	137	153	Cell"	"[{""token"": ""Vandetanib"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""tumor cell"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 137, ""end_span"": 153, ""type"": ""Cell""}]"
c - Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor - beta signaling in diffuse - type gastric carcinoma.	"c - Ski	0	7	Gene_or_gene_product"	"tumor	32	37	Cancer"	"transforming growth factor - beta	84	117	Gene_or_gene_product"	"gastric carcinoma	146	163	Cancer"	"[{""token"": ""c - Ski"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""transforming growth factor - beta"", ""start_span"": 84, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 146, ""end_span"": 163, ""type"": ""Cancer""}]"
c - Ski, originally identified as a proto - oncogene product, is an important negative regulator of transforming growth factor ( TGF) - beta family signaling through interaction with Smad2, Smad3, and Smad4.	"c - Ski	0	7	Gene_or_gene_product"	"Smad2	183	188	Gene_or_gene_product"	"Smad3	190	195	Gene_or_gene_product"	"Smad4	201	206	Gene_or_gene_product"	"[{""token"": ""c - Ski"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad2"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad3"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad4"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}]"
Here, we examined the function of c - Ski in human diffuse - type gastric carcinoma OCUM - 2MLN cells.	"c - Ski	34	41	Gene_or_gene_product"	"human	45	50	Organism"	"gastric carcinoma	66	83	Cancer"	"OCUM - 2MLN cells	84	101	Cell"	"[{""token"": ""c - Ski"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""gastric carcinoma"", ""start_span"": 66, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""OCUM - 2MLN cells"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Cell""}]"
We previously reported that VEGF induces DSCR - 1s expression in endothelial cells, which in turn negatively feeds back to attenuate endothelial cell activation.	"VEGF	28	32	Gene_or_gene_product"	"DSCR - 1s	41	50	Gene_or_gene_product"	"endothelial cells	65	82	Cell"	"endothelial cell	133	149	Cell"	"[{""token"": ""VEGF"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 133, ""end_span"": 149, ""type"": ""Cell""}]"
Collectively, these data suggest that the DSCR1s promoter directs vascular bed - specific expression in activated endothelium and that DSCR - 1s serves to dampen the host response to infection.	"DSCR1s	42	48	Gene_or_gene_product"	"vascular bed	66	78	Multi"	"endothelium	114	125	Tissue"	"DSCR - 1s	135	144	Gene_or_gene_product"	"[{""token"": ""DSCR1s"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular bed"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Multi""}, {""token"": ""endothelium"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""DSCR - 1s"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
A portion of bilateral radial bones of a rabbit were removed as free bone grafts, whose periostea were peeled off.	"bilateral radial bones	13	35	Organ"	"rabbit	41	47	Organism"	"bone grafts	69	80	Multi"	"periostea	88	97	Tissue"	"[{""token"": ""bilateral radial bones"", ""start_span"": 13, ""end_span"": 35, ""type"": ""Organ""}, {""token"": ""rabbit"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""bone grafts"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""periostea"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Tissue""}]"
Here, we demonstrate that D2 dopamine receptor ( D2DR) colocalizes with VEGFR - 2 at the cell surface.	"D2 dopamine receptor	26	46	Gene_or_gene_product"	"D2DR	49	53	Gene_or_gene_product"	"VEGFR - 2	72	81	Gene_or_gene_product"	"cell surface	89	101	Cellular_component"	"[{""token"": ""D2 dopamine receptor"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2DR"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell surface"", ""start_span"": 89, ""end_span"": 101, ""type"": ""Cellular_component""}]"
Dopamine administration leads to increased VEGF - induced phosphorylation of SHP - 2 and this increased phosphorylation parallels the increased phosphatase activity of SHP - 2.	"Dopamine	0	8	Chemical"	"VEGF	43	47	Gene_or_gene_product"	"SHP - 2	77	84	Gene_or_gene_product"	"SHP - 2	168	175	Gene_or_gene_product"	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""SHP - 2"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""SHP - 2"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"
Glioma tumor stem - like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal - derived factor 1.	"Glioma tumor stem - like cells	0	30	Cell"	"tumor	39	44	Cancer"	"vascular endothelial growth factor	81	115	Gene_or_gene_product"	"stromal - derived factor 1	120	146	Gene_or_gene_product"	"[{""token"": ""Glioma tumor stem - like cells"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 81, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal - derived factor 1"", ""start_span"": 120, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"
CSC - high C6 cell cultures also induced higher levels of endothelial cell proliferation and tubule organization in vitro compared with CSC - low cultures.	"CSC - high C6 cell cultures	0	27	Cell"	"endothelial cell	58	74	Cell"	"tubule	93	99	Tissue"	"CSC - low cultures	136	154	Cell"	"[{""token"": ""CSC - high C6 cell cultures"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""tubule"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Tissue""}, {""token"": ""CSC - low cultures"", ""start_span"": 136, ""end_span"": 154, ""type"": ""Cell""}]"
It is hypothesized that the NO derived from inducible NOS ( iNOS) may promote survival of ischemic tissue through angiogenesis.	"NO	28	30	Chemical"	"inducible NOS	44	57	Gene_or_gene_product"	"iNOS	60	64	Gene_or_gene_product"	"ischemic tissue	90	105	Tissue"	"[{""token"": ""NO"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""inducible NOS"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""iNOS"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""ischemic tissue"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Tissue""}]"
In groups 1 & 2, hindlimb ischemia was induced by ligation of femoral artery and they received L - NIL and saline respectively.	"hindlimb	17	25	Organism_subdivision"	"femoral artery	62	76	Multi"	"L - NIL	95	102	Chemical"	"saline	107	113	Chemical"	"[{""token"": ""hindlimb"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Organism_subdivision""}, {""token"": ""femoral artery"", ""start_span"": 62, ""end_span"": 76, ""type"": ""Multi""}, {""token"": ""L - NIL"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""saline"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Chemical""}]"
After 21 days, the serum concentration of nitrite, capillary density and expression of HIF1alpha were determined.	"serum	19	24	Organism_substance"	"nitrite	42	49	Chemical"	"capillary	51	60	Tissue"	"HIF1alpha	87	96	Gene_or_gene_product"	"[{""token"": ""serum"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism_substance""}, {""token"": ""nitrite"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""capillary"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Tissue""}, {""token"": ""HIF1alpha"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"
The capillary density in group 1 ( ischemia + L - NIL) was significantly different from group 2 ( ischemia + saline); group 1: 360. 33 + / - 77. 02, group 2: 549 + / - 81. 85 / mm2, p < 0. 05). In addition, expression of HIF1alpha was significantly increased in ischemic groups ( p < 0. 05).	"capillary	4	13	Tissue"	"L - NIL	46	53	Chemical"	"saline	109	115	Chemical"	"HIF1alpha	221	230	Gene_or_gene_product"	"[{""token"": ""capillary"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Tissue""}, {""token"": ""L - NIL"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""saline"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Chemical""}, {""token"": ""HIF1alpha"", ""start_span"": 221, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}]"
CONCLUSION: Selective inhibition of iNOS by L - NIL inhibits angiogenesis in a hindlimb ischemic rat model.	"iNOS	36	40	Gene_or_gene_product"	"L - NIL	44	51	Chemical"	"hindlimb	79	87	Organism_subdivision"	"rat	97	100	Organism"	"[{""token"": ""iNOS"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - NIL"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""hindlimb"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Organism_subdivision""}, {""token"": ""rat"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Organism""}]"
Treatment of cells with PKC inhibitors also potentiated anchorage - independent growth of BPDE treated cells on soft agar.	"cells	13	18	Cell"	"PKC	24	27	Gene_or_gene_product"	"BPDE	90	94	Chemical"	"cells	103	108	Cell"	"[{""token"": ""cells"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""PKC"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Cell""}]"
Sequence analysis of CDC4 / FBXW7 was carried out on gastric carcinoma cell lines and xenografts.	"CDC4	21	25	Gene_or_gene_product"	"FBXW7	28	33	Gene_or_gene_product"	"gastric carcinoma cell lines	53	81	Cell"	"xenografts	86	96	Cancer"	"[{""token"": ""CDC4"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma cell lines"", ""start_span"": 53, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""xenografts"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Cancer""}]"
No CDC4 / FBXW7 mutations were found and loss of CDC4 / FBXW7 did not correlate with ploidy status.	"CDC4	3	7	Gene_or_gene_product"	"FBXW7	10	15	Gene_or_gene_product"	"CDC4	49	53	Gene_or_gene_product"	"FBXW7	56	61	Gene_or_gene_product"	"[{""token"": ""CDC4"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDC4"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}]"
Overexpression of Bax inhibitor - 1 ( BI - 1) induces cell transformation in NIH3T3 cells.	"Bax inhibitor - 1	18	35	Gene_or_gene_product"	"BI - 1	38	44	Gene_or_gene_product"	"cell	54	58	Cell"	"NIH3T3 cells	77	89	Cell"	"[{""token"": ""Bax inhibitor - 1"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""BI - 1"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""NIH3T3 cells"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Cell""}]"
The expression of MMP - 2 / 9 of AGS cells was inhibited by 2. 0 microM of GA.	"MMP - 2	18	25	Gene_or_gene_product"	"9	28	29	Gene_or_gene_product"	"AGS cells	33	42	Cell"	"GA	75	77	Chemical"	"[{""token"": ""MMP - 2"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 28, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""AGS cells"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""GA"", ""start_span"": 75, ""end_span"": 77, ""type"": ""Chemical""}]"
It is possible that the suppressive effect of GA on MMP - 2 / 9 might involve the inhibition of NF - kappaB activity.	"GA	46	48	Chemical"	"MMP - 2	52	59	Gene_or_gene_product"	"9	62	63	Gene_or_gene_product"	"NF - kappaB	96	107	Gene_or_gene_product"	"[{""token"": ""GA"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""MMP - 2"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 62, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"
p - XSC also decreases Akt phosphorylation as well as Akt - specific phosphorylation of the AR.	"p - XSC	0	7	Chemical"	"Akt	23	26	Gene_or_gene_product"	"Akt	54	57	Gene_or_gene_product"	"AR	92	94	Gene_or_gene_product"	"[{""token"": ""p - XSC"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}]"
It activated multicaspases, and increased the activities of caspase - 8 and caspase - 9 in both MG - 63 and SaOS - 2 cells.	"caspase - 8	60	71	Gene_or_gene_product"	"caspase - 9	76	87	Gene_or_gene_product"	"MG - 63	96	103	Cell"	"SaOS - 2 cells	108	122	Cell"	"[{""token"": ""caspase - 8"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 9"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""MG - 63"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""SaOS - 2 cells"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Cell""}]"
Thymosin beta - 4 ( TB4) is an actin - sequestering protein to control cytoskeletal reorganization.	"Thymosin beta - 4	0	17	Gene_or_gene_product"	"TB4	20	23	Gene_or_gene_product"	"actin	31	36	Gene_or_gene_product"	"cytoskeletal	71	83	Cellular_component"	"[{""token"": ""Thymosin beta - 4"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""TB4"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoskeletal"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Cellular_component""}]"
We also found an increase of tumor growth and lung metastasis count in TB4 - Tg mice as compared to wildtype mice.	"tumor	29	34	Cancer"	"lung	46	50	Organ"	"TB4	71	74	Gene_or_gene_product"	"mice	80	84	Organism"	"[{""token"": ""tumor"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Organ""}, {""token"": ""TB4"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Organism""}]"
Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6 - phosphofructo - 2 - kinase / fructose - 2, 6 - bisphosphatase 2 in prostate cancer cells.	"Androgen	0	8	Chemical"	"lipid	43	48	Chemical"	"hexokinase 2	91	103	Gene_or_gene_product"	"prostate cancer cells	179	200	Cell"	"[{""token"": ""Androgen"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""lipid"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""hexokinase 2"", ""start_span"": 91, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer cells"", ""start_span"": 179, ""end_span"": 200, ""type"": ""Cell""}]"
Glucose uptake and lipogenesis were severely blocked by knocking - down of PFKFB2 using siRNA ( small interfering RNA) or by inhibition of PFK - 2 activity with LY294002 treatment.	"Glucose	0	7	Chemical"	"PFKFB2	75	81	Gene_or_gene_product"	"PFK - 2	139	146	Gene_or_gene_product"	"LY294002	161	169	Chemical"	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""PFKFB2"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFK - 2"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""LY294002"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Chemical""}]"
Our earlier studies showed that DATS induced apoptosis in human colon cancer HT29 and colo 205 cell lines in vitro.	"DATS	32	36	Chemical"	"human	58	63	Organism"	"colon cancer HT29	64	81	Cell"	"colo 205 cell lines	86	105	Cell"	"[{""token"": ""DATS"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""colon cancer HT29"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""colo 205 cell lines"", ""start_span"": 86, ""end_span"": 105, ""type"": ""Cell""}]"
Tumor volume and total hemoglobin in allograft mice treated with 50 mg / kg DATS were significantly smaller than that in the control group.	"Tumor	0	5	Cancer"	"hemoglobin	23	33	Gene_or_gene_product"	"mice	47	51	Organism"	"DATS	76	80	Chemical"	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""hemoglobin"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""DATS"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Chemical""}]"
The high - mobility group A2 gene ( HMGA2) is one of the most frequently amplified genes in human cancers.	"high - mobility group A2	4	28	Gene_or_gene_product"	"HMGA2	36	41	Gene_or_gene_product"	"human	92	97	Organism"	"cancers	98	105	Cancer"	"[{""token"": ""high - mobility group A2"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Cancer""}]"
Importantly, HMGA2 partially replaces the function of hTERT during the tumorigenic transformation of normal human fibroblasts.	"HMGA2	13	18	Gene_or_gene_product"	"hTERT	54	59	Gene_or_gene_product"	"human	108	113	Organism"	"fibroblasts	114	125	Cell"	"[{""token"": ""HMGA2"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Cell""}]"
These findings are potentially clinically relevant, because HMGA2 expression is reported to be upregulated in a number of human cancers as telomere maintenance is essential for tumorigenesis.	"HMGA2	60	65	Gene_or_gene_product"	"human	122	127	Organism"	"cancers	128	135	Cancer"	"telomere	139	147	Cellular_component"	"[{""token"": ""HMGA2"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Cancer""}, {""token"": ""telomere"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Cellular_component""}]"
Furthermore, we found a significant association between tumour location, tumour grade and node status and the methylation status of the APC gene ( p < = 0. 05).	"tumour	56	62	Cancer"	"tumour	73	79	Cancer"	"node	90	94	Multi"	"APC	136	139	Gene_or_gene_product"	"[{""token"": ""tumour"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""node"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Multi""}, {""token"": ""APC"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"
Notably, AglRhz inhibits insulin - like growth factor ( IGF) - 1 - induced AP - 1 activity and cell transformation in JB6 Cl41 cells.	"AglRhz	9	15	Chemical"	"AP - 1	75	81	Gene_or_gene_product"	"cell	95	99	Cell"	"JB6 Cl41 cells	118	132	Cell"	"[{""token"": ""AglRhz"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""JB6 Cl41 cells"", ""start_span"": 118, ""end_span"": 132, ""type"": ""Cell""}]"
Oral squamous cell carcinoma ( OSCC) often metastasizes to the lymph nodes, and these enzymes may be significant in the survival of patients with this disease.	"Oral squamous cell carcinoma	0	28	Cancer"	"OSCC	31	35	Cancer"	"lymph nodes	63	74	Multi"	"patients	132	140	Organism"	"[{""token"": ""Oral squamous cell carcinoma"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""OSCC"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Organism""}]"
TS and DPD proteins were overexpressed in primary OSCC compared to that in normal mucosa.	"TS	0	2	Gene_or_gene_product"	"DPD	7	10	Gene_or_gene_product"	"primary OSCC	42	54	Cancer"	"mucosa	82	88	Multi"	"[{""token"": ""TS"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene_or_gene_product""}, {""token"": ""DPD"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary OSCC"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""mucosa"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Multi""}]"
DPD expression did not significantly correlate with the occurrence of lymph node metastasis, nor was it different between primary oral cancer cells and cervical metastases.	"DPD	0	3	Gene_or_gene_product"	"lymph node	70	80	Multi"	"oral cancer cells	130	147	Cell"	"cervical	152	160	Multi"	"[{""token"": ""DPD"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""oral cancer cells"", ""start_span"": 130, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""cervical"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Multi""}]"
Simian virus 40 ( SV40) is a powerful tool to study cellular transformation in vitro, as well as tumor development and progression in vivo.	"Simian virus 40	0	15	Organism"	"SV40	18	22	Organism"	"cellular	52	60	Cell"	"tumor	97	102	Cancer"	"[{""token"": ""Simian virus 40"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""SV40"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cancer""}]"
However, tumor incidence was lower and life span was significantly longer in WAP - mutCK1delta / WAP - T bi - transgenic animals.	"tumor	9	14	Cancer"	"WAP	77	80	Gene_or_gene_product"	"mutCK1delta	83	94	Gene_or_gene_product"	"WAP	97	100	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""WAP"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""mutCK1delta"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}]"
Multi - step neoplastic transformation of normal human fibroblasts by Co - 60 gamma rays and Ha - ras oncogenes.	"human	49	54	Organism"	"fibroblasts	55	66	Cell"	"Co - 60	70	77	Chemical"	"Ha - ras	93	101	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""Co - 60"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""Ha - ras"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"
As reported previously ( Namba et al., 1985; Namba, 1985), normal human fibroblasts were transformed into immortal cells with abnormal karyotypes by Co - 60 gamma - ray irradiation.	"human	66	71	Organism"	"fibroblasts	72	83	Cell"	"immortal cells	106	120	Cell"	"Co - 60	149	156	Chemical"	"[{""token"": ""human"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""immortal cells"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""Co - 60"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical""}]"
One theoretical possibility is that mast cells may prepare the matrix, perhaps by slow release of heparin, so that capillary sprouts can more easily move through it toward their angiogenic target.	"mast cells	36	46	Cell"	"matrix	63	69	Cellular_component"	"heparin	98	105	Chemical"	"capillary sprouts	115	132	Tissue"	"[{""token"": ""mast cells"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Cellular_component""}, {""token"": ""heparin"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""capillary sprouts"", ""start_span"": 115, ""end_span"": 132, ""type"": ""Tissue""}]"
Protein kinase activities in immune complexes of simian virus 40 large T - antigen and transformation - associated cellular p53 protein.	"simian virus 40	49	64	Organism"	"large T - antigen	65	82	Gene_or_gene_product"	"cellular	115	123	Cell"	"p53	124	127	Gene_or_gene_product"	"[{""token"": ""simian virus 40"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""large T - antigen"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"
These assays yielded mainly the viral large T - antigen and, in particular, the associated cellular p53 as endogenous substrates.	"viral	32	37	Organism"	"large T - antigen	38	55	Gene_or_gene_product"	"cellular	91	99	Cell"	"p53	100	103	Gene_or_gene_product"	"[{""token"": ""viral"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""large T - antigen"", ""start_span"": 38, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}]"
The kinase reactions showed preference for ATP and MgCl2 instead of GTP or MnCl2.	"ATP	43	46	Chemical"	"MgCl2	51	56	Chemical"	"GTP	68	71	Chemical"	"MnCl2	75	80	Chemical"	"[{""token"": ""ATP"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""MgCl2"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""GTP"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""MnCl2"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Chemical""}]"
Suppressed transformation and induced differentiation of HER - 2 / neu - overexpressing breast cancer cells by emodin.	"HER - 2	57	64	Gene_or_gene_product"	"neu	67	70	Gene_or_gene_product"	"breast cancer cells	88	107	Cell"	"emodin	111	117	Chemical"	"[{""token"": ""HER - 2"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 88, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""emodin"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Chemical""}]"
These results may have chemotherapeutic implications for using emodin to target HER - 2 / neu - overexpressing cancer cells.	"emodin	63	69	Chemical"	"HER - 2	80	87	Gene_or_gene_product"	"neu	90	93	Gene_or_gene_product"	"cancer cells	111	123	Cell"	"[{""token"": ""emodin"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""HER - 2"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Cell""}]"
Somatic cell hybrids between LTA and NIH 3T3 cells are tumorigenic, metastatic and ras - responsive.	"Somatic cell hybrids	0	20	Cell"	"LTA	29	32	Cell"	"NIH 3T3 cells	37	50	Cell"	"ras	83	86	Gene_or_gene_product"	"[{""token"": ""Somatic cell hybrids"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""LTA"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""NIH 3T3 cells"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}]"
All four metastatic hybrids expressed 60 - 72 kDa gelatinase activity, while three of them also had 92 kDa activity and one had only minimal 92 kDa activity.	"hybrids	20	27	Cell"	"60 - 72 kDa gelatinase	38	60	Gene_or_gene_product"	"92 kDa	100	106	Gene_or_gene_product"	"92 kDa	141	147	Gene_or_gene_product"	"[{""token"": ""hybrids"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""60 - 72 kDa gelatinase"", ""start_span"": 38, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""92 kDa"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""92 kDa"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
Levels of RNA for tissue inhibitors of metalloproteinases ( TIMP - 1, TIMP - 2) were relatively constant, suggesting independent regulation of type IV collagenases and their inhibitors.	"tissue	18	24	Tissue"	"TIMP - 1	60	68	Gene_or_gene_product"	"TIMP - 2	70	78	Gene_or_gene_product"	"type IV collagenases	143	163	Gene_or_gene_product"	"[{""token"": ""tissue"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Tissue""}, {""token"": ""TIMP - 1"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 2"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagenases"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"
Overexpression of ST3 correlated with the progression of human colorectal tumors toward local invasion and liver metastasis.	"ST3	18	21	Gene_or_gene_product"	"human	57	62	Organism"	"colorectal tumors	63	80	Cancer"	"liver	107	112	Organ"	"[{""token"": ""ST3"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""colorectal tumors"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organ""}]"
Collagen XII is a complex multidomain protein associated with the surface of interstitial collagen fibrils.	"Collagen XII	0	12	Gene_or_gene_product"	"interstitial	77	89	Organ"	"collagen	90	98	Gene_or_gene_product"	"fibrils	99	106	Cellular_component"	"[{""token"": ""Collagen XII"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""interstitial"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Organ""}, {""token"": ""collagen"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrils"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Cellular_component""}]"
H4 cells formed tight, round spheroids whereas H5 cells formed loose, grape - like structures.	"H4 cells	0	8	Cell"	"spheroids	29	38	Cell"	"H5 cells	47	55	Cell"	"grape - like structures	70	93	Cell"	"[{""token"": ""H4 cells"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""H5 cells"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""grape - like structures"", ""start_span"": 70, ""end_span"": 93, ""type"": ""Cell""}]"
Tumors of H4 cells were well perfused, unlike tumors of H5 cells which were highly necrotic.	"Tumors	0	6	Cancer"	"H4 cells	10	18	Cell"	"tumors	46	52	Cancer"	"H5 cells	56	64	Cell"	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""H4 cells"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""H5 cells"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Cell""}]"
Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts.	"Human cytomegalovirus	0	21	Organism"	"cellular	45	53	Cell"	"p53	62	65	Gene_or_gene_product"	"fibroblasts	78	89	Cell"	"[{""token"": ""Human cytomegalovirus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cell""}]"
Our results indicate that HCMV elevates cellular p53 levels on the order of 10 - to 20 - fold in infected fibroblasts.	"HCMV	26	30	Organism"	"cellular	40	48	Cell"	"p53	49	52	Gene_or_gene_product"	"fibroblasts	106	117	Cell"	"[{""token"": ""HCMV"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Cell""}]"
The induction of elevated p53 levels commenced at immediate - early times of the HCMV multiplication cycle ( 6 h postinfection) and reached maximal levels by 24 h postinfection, before most of the HCMV DNA synthesis was initiated.	"p53	26	29	Gene_or_gene_product"	"HCMV	81	85	Organism"	"HCMV	197	201	Organism"	"DNA	202	205	Cellular_component"	"[{""token"": ""p53"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""HCMV"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""HCMV"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""DNA"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Cellular_component""}]"
Point mutations of H - ras however, were identified in three distant metastatic pituitary tumor secondaries, but not in their respective primary pituitary carcinomas, or in six invasive adenomas.	"H - ras	19	26	Gene_or_gene_product"	"pituitary tumor secondaries	80	107	Cancer"	"primary pituitary carcinomas	137	165	Cancer"	"adenomas	186	194	Cancer"	"[{""token"": ""H - ras"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""pituitary tumor secondaries"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""primary pituitary carcinomas"", ""start_span"": 137, ""end_span"": 165, ""type"": ""Cancer""}, {""token"": ""adenomas"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Cancer""}]"
Overexpression of Glut - 1 glucose transporter in human breast cancer.	"Glut - 1	18	26	Gene_or_gene_product"	"glucose	27	34	Chemical"	"human	50	55	Organism"	"breast cancer	56	69	Cancer"	"[{""token"": ""Glut - 1"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Cancer""}]"
BACKGROUND: Breast cancers have higher than normal glucose metabolism, but the mechanism of glucose entry into these tumors is not well understood.	"Breast cancers	12	26	Cancer"	"glucose	51	58	Chemical"	"glucose	92	99	Chemical"	"tumors	117	123	Cancer"	"[{""token"": ""Breast cancers"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Cancer""}]"
CONCLUSIONS: Higher expression of the glucose transporter Glut - 1 by breast cancer cells compared with the healthy breast tissue is common.	"glucose	38	45	Chemical"	"Glut - 1	58	66	Gene_or_gene_product"	"breast cancer cells	70	89	Cell"	"healthy breast tissue	108	129	Tissue"	"[{""token"": ""glucose"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""Glut - 1"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""healthy breast tissue"", ""start_span"": 108, ""end_span"": 129, ""type"": ""Tissue""}]"
Somatostatin receptors were detected in peritumoral veins of various human cancer tissue specimens.	"Somatostatin receptors	0	22	Gene_or_gene_product"	"peritumoral veins	40	57	Multi"	"human	69	74	Organism"	"cancer tissue specimens	75	98	Tissue"	"[{""token"": ""Somatostatin receptors"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""peritumoral veins"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""cancer tissue specimens"", ""start_span"": 75, ""end_span"": 98, ""type"": ""Tissue""}]"
In colonic carcinoma specimens, the peritumoral vessels expressed a high density of somatostatin receptors, whereas the neoplastic tissue itself was receptor - negative in many cases.	"colonic carcinoma specimens	3	30	Cancer"	"peritumoral vessels	36	55	Multi"	"somatostatin receptors	84	106	Gene_or_gene_product"	"neoplastic tissue	120	137	Tissue"	"[{""token"": ""colonic carcinoma specimens"", ""start_span"": 3, ""end_span"": 30, ""type"": ""Cancer""}, {""token"": ""peritumoral vessels"", ""start_span"": 36, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""somatostatin receptors"", ""start_span"": 84, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplastic tissue"", ""start_span"": 120, ""end_span"": 137, ""type"": ""Tissue""}]"
They exhibited specific and high - affinity binding of somatostatin - 14, somatostatin - 28 and octreotide, suggesting a preferential expression of the SSTR2 receptor subtype.	"somatostatin - 14	55	72	Gene_or_gene_product"	"somatostatin - 28	74	91	Gene_or_gene_product"	"octreotide	96	106	Chemical"	"SSTR2 receptor	152	166	Gene_or_gene_product"	"[{""token"": ""somatostatin - 14"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatostatin - 28"", ""start_span"": 74, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""octreotide"", ""start_span"": 96, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""SSTR2 receptor"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"
E - cadherin is a Ca ( 2 +) - dependent cell - cell adhesion molecule, which is mainly expressed in epithelial cells.	"E - cadherin	0	12	Gene_or_gene_product"	"cell	40	44	Cell"	"cell	47	51	Cell"	"epithelial cells	100	116	Cell"	"[{""token"": ""E - cadherin"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""epithelial cells"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Cell""}]"
The data provide an example of coordinated changes in the expression of two cell adhesion molecules, syndecan - 1 and E - cadherin during epithelial cell transformation.	"cell	76	80	Cell"	"syndecan - 1	101	113	Gene_or_gene_product"	"E - cadherin	118	130	Gene_or_gene_product"	"epithelial cell	138	153	Cell"	"[{""token"": ""cell"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""syndecan - 1"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial cell"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Cell""}]"
Thus, 5T4 molecules can deliver signals through both the extracellular and intracellular domains, and the resultant effects are consistent with a role for 5T4 molecules in invasion processes.	"5T4	6	9	Gene_or_gene_product"	"extracellular	57	70	Immaterial_anatomical_entity"	"intracellular	75	88	Immaterial_anatomical_entity"	"5T4	155	158	Gene_or_gene_product"	"[{""token"": ""5T4"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intracellular"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""5T4"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"
Certain carcinostatic agents induce the expression of E - selectin on endothelial cells and enhance the expression of carbohydrate ligands on cancer cells.	"E - selectin	54	66	Gene_or_gene_product"	"endothelial cells	70	87	Cell"	"carbohydrate	118	130	Chemical"	"cancer cells	142	154	Cell"	"[{""token"": ""E - selectin"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""carbohydrate"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Cell""}]"
In the trans - splenic hepatic metastasis model using nude mice, the augmentation of cancer metastasis was observed by the treatment of carcinostatic agents.	"trans - splenic	7	22	Immaterial_anatomical_entity"	"hepatic	23	30	Organ"	"nude mice	54	63	Organism"	"cancer	85	91	Cancer"	"[{""token"": ""trans - splenic"", ""start_span"": 7, ""end_span"": 22, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""hepatic"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Organ""}, {""token"": ""nude mice"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Cancer""}]"
We have, therefore, examined components of this plasminogen activating system in patients with Non - Small Cell Lung Cancer ( NSCLC).	"plasminogen	48	59	Gene_or_gene_product"	"patients	81	89	Organism"	"Non - Small Cell Lung Cancer	95	123	Cancer"	"NSCLC	126	131	Cancer"	"[{""token"": ""plasminogen"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Organism""}, {""token"": ""Non - Small Cell Lung Cancer"", ""start_span"": 95, ""end_span"": 123, ""type"": ""Cancer""}, {""token"": ""NSCLC"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Cancer""}]"
Immunohistochemically stained sections of tumour were allocated a score for stain intensity and results correlated to: survival; tumour stage ( T); nodal stage ( N); stage grouping ( I to IIIb), survival status and sex.	"sections	30	38	Cancer"	"tumour	42	48	Cancer"	"tumour	129	135	Cancer"	"nodal	148	153	Multi"	"[{""token"": ""sections"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Cancer""}, {""token"": ""nodal"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Multi""}]"
There was a significant positive relationship between PAI - 1 levels and N - stage ( p = < 0. 05), presence of nodal metastases ( p = < 0. 05), stage grouping ( p = < 0. 01) and extent of disease ( p = < 0. 05) in the total group and the SCC subgroup, but not adenocarcinoma.	"PAI - 1	54	61	Gene_or_gene_product"	"nodal	111	116	Multi"	"SCC	238	241	Cancer"	"adenocarcinoma	260	274	Cancer"	"[{""token"": ""PAI - 1"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""nodal"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Multi""}, {""token"": ""SCC"", ""start_span"": 238, ""end_span"": 241, ""type"": ""Cancer""}, {""token"": ""adenocarcinoma"", ""start_span"": 260, ""end_span"": 274, ""type"": ""Cancer""}]"
